Saredutant is a neurokinin-2 (NK2) receptor antagonist investigated for its potential application in the treatment of major depressive disorder and generalized anxiety disorder. As an experimental therapeutic… Read more
Saredutant is a neurokinin-2 (NK2) receptor antagonist investigated for its potential application in the treatment of major depressive disorder and generalized anxiety disorder. As an experimental therapeutic agent, it represents a distinct class of compounds that function by blocking the effects of neurokinin A, serving as an area of interest in psychopharmacological research. Our catalogue offers a comprehensive selection of related products, including saredutant impurities, metabolites, and stable isotope labelled compounds, to support rigorous pharmaceutical development. These high-quality reference standards are essential for laboratories engaged in precise analytical testing, method validation, and impurity profiling. By providing these critical materials, we enable researchers and quality control professionals to ensure accuracy and consistency in their experimental workflows, facilitating the development and evaluation of this novel chemical entity throughout its lifecycle.